Thrombolysis in acute MI: recent randomized trials.
Several large trials of intravenous thrombolysis in eligible patients are reviewed; all show significant benefits, including improved ventricular function, reduced mortality, or, in some cases, both.
Pitt
B
B
Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.
D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D011897:Random Allocation
D005343:Fibrinolytic Agents